Heart Foundation Catalyst Grant
Invest in the Future of Preventative Healthcare
Message from the heart: a new solution to screen for blood vessel calcification
Why invest in Our Solution?
- Cardiovascular Disease (CVD) is the world’s #1 killer & costs the Australian Health System $12.7B per year.
- Abdominal Aortic Calcification (AAC) often detectable earlier compared to the vessels of the heart, providing an opportunity for earlier detection and prevention.
- Our AI-powered solution identifies AAC on bone density scanning and can predict those patients which are 1.8-2x more likely to have a future CVD event.
Competitive Advantage
- We are the only comprehensive solution available that can offer automated AAC detection in seconds (vs manual assessment by a trained clinician)
- Our solution predicts heart attacks, strokes, falls, fracture, and dementia
- We have exclusive access to some of the world’s largest annotated datasets and two global leaders in AAC are part of our team
- We have clinical validation and have published our results in leading scientific journals
Investment & Growth Strategy
- Obtained >$6M in research grant funding from 2016 to date, used to understand why AAC occurs, develop and validate our solution
- We have developed a clear strategy to enter the clinical, health & wellness markets
- We are seeking equity investment to bring our solution to market over the next 3 years
“Join us to save lives globally through early identification of AAC and improved management of CVD risk factors. Use of AAC will be a new tool for researchers, patients and their healthcare providers to reduce health inequities via improved access to low-cost screening and provision of lifesaving health-related information”
